MLAB Mesa Laboratories Inc

Price (delayed)

$110.02

Market cap

$595.1M

P/E Ratio

N/A

Dividend/share

$0.64

EPS

-$47.2

Enterprise value

$788.58M

Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries. ...

Highlights
The gross profit has grown by 2.6% from the previous quarter
The debt has grown by 21% YoY but it has contracted by 4.8% from the previous quarter
The company's quick ratio fell by 13% YoY but it rose by 4.8% QoQ
MLAB's equity has dropped by 64% since the previous quarter and by 63% year-on-year

Key stats

What are the main financial stats of MLAB
Market
Shares outstanding
5.41M
Market cap
$595.1M
Enterprise value
$788.58M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.08
Price to sales (P/S)
2.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.65
Earnings
Revenue
$216.19M
EBIT
-$269.95M
EBITDA
-$238.38M
Free cash flow
$41.57M
Per share
EPS
-$47.2
Free cash flow per share
$7.72
Book value per share
$26.95
Revenue per share
$40.14
TBVPS
$28.4
Balance sheet
Total assets
$446.8M
Total liabilities
$301.4M
Debt
$221.7M
Equity
$145.39M
Working capital
$65.04M
Liquidity
Debt to equity
1.52
Current ratio
2.47
Quick ratio
1.52
Net debt/EBITDA
-0.81
Margins
EBITDA margin
-110.3%
Gross margin
61.6%
Net margin
-117.6%
Operating margin
-124.9%
Efficiency
Return on assets
-41.2%
Return on equity
-76.8%
Return on invested capital
-95.2%
Return on capital employed
-67.1%
Return on sales
-124.9%
Dividend
Dividend yield
0.58%
DPS
$0.64
Payout ratio
N/A

MLAB stock price

How has the Mesa Laboratories stock price performed over time
Intraday
1.69%
1 week
1.76%
1 month
24.77%
1 year
-17.28%
YTD
5.01%
QTD
26.79%

Financial performance

How have Mesa Laboratories's revenue and profit performed over time
Revenue
$216.19M
Gross profit
$133.25M
Operating income
-$269.95M
Net income
-$254.25M
Gross margin
61.6%
Net margin
-117.6%
The gross profit has grown by 2.6% from the previous quarter

Growth

What is Mesa Laboratories's growth rate over time

Valuation

What is Mesa Laboratories stock price valuation
P/E
N/A
P/B
4.08
P/S
2.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.65
MLAB's price to book (P/B) is 85% more than its last 4 quarters average of 2.2 and 32% more than its 5-year quarterly average of 3.1
MLAB's equity has dropped by 64% since the previous quarter and by 63% year-on-year
The P/S is 61% below the 5-year quarterly average of 7.0 and 2.1% below the last 4 quarters average of 2.8

Efficiency

How efficient is Mesa Laboratories business performance

Dividends

What is MLAB's dividend history
DPS
$0.64
Dividend yield
0.58%
Payout ratio
N/A
Recent dividends

Financial health

How did Mesa Laboratories financials performed over time
Mesa Laboratories's total assets is 48% more than its total liabilities
Mesa Laboratories's total assets has decreased by 40% from the previous quarter and by 32% YoY
The company's quick ratio fell by 13% YoY but it rose by 4.8% QoQ
The debt is 52% more than the equity
MLAB's debt to equity has soared by 162% QoQ
MLAB's equity has dropped by 64% since the previous quarter and by 63% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.